In early October 2021, the World Health Organization (WHO) endorsed the first-ever vaccine against malaria, a parasitic disease transmitted by the bite of an infective female Anopheles mosquito.
This achievement is the product of 30 years of research and development.
It is the first against malaria, and the first for any human parasitic disease stated an article recently published by Johns Hopkins Malaria Research Institute.
This WHO endorsement was important since malaria is a significant cause of illness and death in sub-Saharan Africa.
Innovative Malaria Vaccine Offers Travelers Much Needed Protection
Fluvoxamine Cuts Hospitalizations in High-Risk COVID-19 Outpatients
Rate of high-risk COVID-19 outpatients needing prolonged emergency care or transfer to tertiary hospital lower with fluvoxamine versus placebo
Sotrovimab Cuts Risk for COVID-19 Progression in High-Risk Patients
Interim analysis shows lower risk for progression with sotrovimab versus placebo among high-risk patients with mild-to-moderate COVID-19
Vaccination Protects Against Death From SARS-CoV-2 Delta Variant
Scotland cohort study shows vaccination with ChAdOx1 nCoV-19, BNT162b2 highly effective for preventing deaths caused by delta variant
Worldwide Routine Vaccination Coverage Down From 2019 to 2020
Global estimates decreased for coverage with third dose of DTP and polio vaccine, first dose of measles-containing vaccine
Nearly 59,000 Meatpacking Workers Caught COVID-19
And 269 workers died as the pandemic raged through the industry last year
COVID-19 Vaccination Not Linked to First-Trimester Miscarriage
Among women with miscarriage, adjusted odds ratios for COVID-19 vaccination in previous three and five weeks were 0.91 and 0.81